Credit Suisse »

Alnylam Pharmaceuticals shares owned by Credit Suisse

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Credit Suisse

Quarter filed Position value Share count Share price at filing
2013-03-31 $3.3M 127k 25.97
2012-09-30 $2.4M 126k 18.80
2011-09-30 $289k 44k 6.53
2011-06-30 $619k 66k 9.37
2011-03-31 $736k 77k 9.59
2010-12-31 $848k 86k 9.86